Table of ContentsFebruary 2001
EDITORIAL
Putting an End to the Guesswork
Assays that measure the susceptibility of a particular viral isolate to particular antiretroviral agents help clinicians devise successful successor regimens for patients who are failing therapy
OPTIMAL MEDICAL MANAGEMENT
Entering the Era of Truly Individualized Antiretroviral TherapyANDREW D. LUBER, PHARM.D., and W. DAVID HARDY, M.D. & Clinical Considerations in Therapeutic Drug Monitoring
NEWSLINE Newsline...Newsline...Newsline...Update: Subcutaneous interleukin-2: Investigators observe dose-related increases in CD4 counts -- without increases in HIV RNA . . . Update: Treatment of lipodystrophy: Metformin reduces insulin resistance and visceral fat deposits . . . Scrub typhus and HIV co-infection: Does O. tsugamushi inhibit syncytia formation in seropositive patients?
PULLOUT Trekking with AIDS, Part 3: A Special Report
An advocate for people living with AIDS proves that HIV infection is no impediment to completing this country's oldest and most famous wilderness trail
CASE MANAGEMENT
Michael T., a Longterm Survivor Who Is Failing His Fifth Salvage Regimen Phenotype assay results -- reproduced here -- suggest a therapeutic option for a patient who has developed high-level resistance to two classes of antiretroviral agents Back to the February 2001 HIV Newsline contents page.
This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline.
|
|